Summary of Disaggregation of Total Revenues |
The following table disaggregates total revenues from external customers by product sales, royalty revenue, and collaboration and license revenue (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, |
|
September 30, |
|
|
2024 |
|
|
2023 |
|
2024 |
|
|
2023 |
|
Product sales: |
|
|
|
|
|
|
|
|
|
|
Crysvita |
$ |
35,604 |
|
|
$ |
19,200 |
|
$ |
112,294 |
|
|
$ |
57,318 |
|
Dojolvi |
|
21,374 |
|
|
|
16,553 |
|
|
57,091 |
|
|
|
47,347 |
|
Mepsevii |
|
9,616 |
|
|
|
5,633 |
|
|
22,372 |
|
|
|
22,552 |
|
Evkeeza |
|
10,657 |
|
|
|
963 |
|
|
21,788 |
|
|
|
1,540 |
|
Total product sales |
|
77,251 |
|
|
|
42,349 |
|
|
213,545 |
|
|
|
128,757 |
|
Crysvita royalty revenue |
|
62,243 |
|
|
|
55,703 |
|
|
181,808 |
|
|
|
106,916 |
|
Collaboration and license revenue: |
|
|
|
|
|
|
|
|
|
|
Crysvita collaboration revenue in Profit- Share Territory |
|
— |
|
|
|
— |
|
|
— |
|
|
|
69,705 |
|
Daiichi Sankyo |
|
— |
|
|
|
— |
|
|
— |
|
|
|
1,479 |
|
Total collaboration and license revenue |
|
— |
|
|
|
— |
|
|
— |
|
|
|
71,184 |
|
Total revenues |
$ |
139,494 |
|
|
$ |
98,052 |
|
$ |
395,353 |
|
|
$ |
306,857 |
|
The following table disaggregates total revenues based on geographic location (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, |
|
September 30, |
|
|
2024 |
|
|
2023 |
|
2024 |
|
|
2023 |
|
North America |
$ |
76,914 |
|
|
$ |
67,811 |
|
$ |
223,485 |
|
|
$ |
214,232 |
|
Latin America |
|
38,048 |
|
|
|
17,229 |
|
|
112,155 |
|
|
|
59,096 |
|
Europe, Middle East, and Africa |
|
22,222 |
|
|
|
13,012 |
|
|
54,352 |
|
|
|
32,351 |
|
Asia-Pacific |
|
2,310 |
|
|
|
— |
|
|
5,361 |
|
|
|
1,178 |
|
Total revenues |
$ |
139,494 |
|
|
$ |
98,052 |
|
$ |
395,353 |
|
|
$ |
306,857 |
|
|